24/7 Patient Assistance: 760-405-8205

Gina Amato, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

  • Bio & Insurance Information
  • Education & Training


    University of Miami Miller

    Medical School


    Jackson Memorial Hospital - Jackson Health System



    University of South Florida


  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Northside Hospital-Forsyth

    Languages: English/Spanish

    (404) 778-1900

    1365 Clifton Road North East

    Atlanta, GA 30322

    Read More
  • Publications & Memberships

    Dr. Gina Amato has contributed to 3 publications.

    Phase II study of sunitinib malate, a multitargeted tyrosine kinase inhibitor in patients with relapsed or refractory soft tissue sarcomas. Focus on three prevalent hi.

    Mahmood ST, Agresta S, Vigil CE, Zhao X, Han G, D'Amato G, Calitri CE, Dean M, Garrett C, Schell MJ, Antonia S, Chiappori A; Int. J. Cancer. 2011-10-15.

    See more >>

    Phase II study of sunitinib malate (SM) in subjects with metastatic and/or surgically unresectable non-GIST soft tissue sarcomas.

    Vigil CE, Chiappori AA, Williams CA, Shrager HH, Murray BL, Letson DG, Sullivan DM, Garrett CR, D'Amato GZ, Agresta SV; J. Clin. Oncol.. 2008-05-20.

    See more >>

    Preliminary efficacy and safety results of glufosfamide (GLU) in relapsed soft tissue sarcoma: Results of a phase II trial.

    D'Amato GZ, Verschraegen CF, Cranmer LD, Ganjoo KN, Rosen G, Adkins DR, Mendelson DS, Langmuir VK, Kroll S; J. Clin. Oncol.. 2008-05-20.

    See more >>